ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe, SCA P...

FDA Recall #D-0213-2021 — Class II — December 17, 2020

Recall #D-0213-2021 Date: December 17, 2020 Classification: Class II Status: Terminated

Product Description

ePHEDrine 25 mg/5 mL in 0.9% Sodium Chloride Injection, Rx Only, 5 mL Single Dose Syringe, SCA Pharmaceuticals 8521 Knoedl Ct., Little Rock, AR, 72205, barcode 70004060409

Reason for Recall

Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit

Recalling Firm

SCA Pharmaceuticals — Windsor, CT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

9416 syringes

Distribution

Product was distributed to hospitals nationwide.

Code Information

Lot # 1220023022, BUD 1/17/2021; 1220023023, BUD 1/17/2021; 1220023029, BUD 1/19/2021; 1220023030, BUD 1/20/2021; 1220023117, BUD 1/25/2021; 1220023145, BUD 1/26/2021 & 1220023166, BUD 1/27/2021.

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated